Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of SPLUNK INC from Q4 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Splunk Inc quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q4 2017 to Q3 2023.
  • Splunk Inc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 31 Oct 2023 was $928M, a 11.4% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

SPLUNK INC Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $928M +$95M +11.4% 31 Oct 2023 10-Q 28 Nov 2023
Q2 2023 $1.52B +$776M +104% 31 Jul 2023 10-Q 24 Aug 2023
Q1 2023 $801M -$12.6M -1.54% 30 Apr 2023 10-Q 25 May 2023
Q4 2022 $691M -$738M -51.7% 31 Jan 2023 10-Q 28 Nov 2023
Q3 2022 $833M -$471M -36.1% 31 Oct 2022 10-Q 28 Nov 2023
Q2 2022 $748M -$1.48B -66.5% 31 Jul 2022 10-Q 24 Aug 2023
Q1 2022 $814M -$1.03B -55.9% 30 Apr 2022 10-Q 25 May 2023
Q4 2021 $1.43B -$342M -19.3% 31 Jan 2022 10-Q 28 Nov 2023
Q3 2021 $1.3B -$348M -21.1% 31 Oct 2021 10-Q 01 Dec 2022
Q2 2021 $2.23B +$763M +52% 31 Jul 2021 10-Q 25 Aug 2022
Q1 2021 $1.85B +$923M +100% 30 Apr 2021 10-Q 26 May 2022
Q4 2020 $1.77B +$992M +127% 31 Jan 2021 10-K 23 Mar 2023
Q3 2020 $1.65B +$779M +89.2% 31 Oct 2020 10-Q 02 Dec 2021
Q2 2020 $1.47B -$204M -12.2% 31 Jul 2020 10-Q 08 Sep 2021
Q1 2020 $923M -$913M -49.7% 30 Apr 2020 10-Q 09 Jun 2021
Q4 2019 $779M -$1.1B -58.5% 31 Jan 2020 10-K 23 Mar 2023
Q3 2019 $873M -$995M -53.2% 31 Oct 2019 10-Q 10 Dec 2020
Q2 2019 $1.67B +$1.25B +298% 31 Jul 2019 10-Q 03 Sep 2020
Q1 2019 $1.84B 30 Apr 2019 10-Q 01 Jun 2020
Q4 2018 $1.88B +$1.33B +244% 31 Jan 2019 10-Q 10 Dec 2020
Q3 2018 $1.87B 31 Oct 2018 10-Q 04 Dec 2019
Q2 2018 $420M 31 Jul 2018 10-Q 05 Sep 2019
Q4 2017 $546M 31 Jan 2018 10-Q 04 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.